ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 410 out of 1456

$529K Total Retail Price of All Prescriptions

Rank: 413 out of 1456

268 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 268 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 268 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 7,750 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 304 247 1 1
OMEPRAZOLE 276 243 2 5
FUROSEMIDE 257 232 3 7
DONEPEZIL HCL 246 246 4 29
ATORVASTATIN CALCIUM 233 186 5 11
LISINOPRIL 232 150 6 3
SIMVASTATIN 205 170 7 2
NAMENDA 196 196 8 38
METOPROLOL TARTRATE 194 170 9 12
WARFARIN SODIUM 183 176 10 21
METFORMIN HCL 173 120 11 8
HYDROCODONE-ACETAMINOPHEN 168 112 S3 12 6
GABAPENTIN 167 143 13 13
RANITIDINE HCL 158 139 14 27
MEGESTROL ACETATE 156 150 R 15 179
POLYETHYLENE GLYCOL 3350 148 148 16 85
CARVEDILOL 144 131 17 20
HYDRALAZINE HCL 126 112 18 48
SPIRONOLACTONE 125 101 19 73
NOVOLIN R 114 114 20 133
TRAMADOL HCL 114 104 20 17
KLOR-CON M20 112 94 22 51
RISPERIDONE 106 79 23 72
FLUTICASONE PROPIONATE 105 91 24 28
POTASSIUM CHLORIDE 104 100 25 15
NOVOLOG 104 82 25 104
LEVOTHYROXINE SODIUM 103 90 27 4
DIOVAN 89 82 28 35
PANTOPRAZOLE SODIUM 84 57 29 43
ESCITALOPRAM OXALATE 83 71 30 74
ALLOPURINOL 77 64 31 31
LANTUS 76 48 32 50
CYMBALTA 71 43 33 52
SPIRIVA 69 65 34 75
AMITRIPTYLINE HCL 68 35 R 35 70
ALENDRONATE SODIUM 65 65 36 36
ADVAIR DISKUS 62 57 37 63
OXYCODONE HCL-ACETAMINOPHEN 59 21 S2 38 132
MELOXICAM 57 57 39 30
ISOSORBIDE MONONITRATE ER 56 52 40 60
MIRTAZAPINE 54 54 41 65
GLIPIZIDE 54 37 41 53
ATENOLOL 52 47 43 18
NAPROXEN 52 51 43 100
ZOLPIDEM TARTRATE 52 48 43 14
OXYBUTYNIN CHLORIDE ER 51 41 46 167
PROAIR HFA 51 50 46 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 40 46 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.